Overview
- Researchers used quantitative susceptibility mapping MRI at baseline in the BIOCARD cohort and tracked participants for up to about 7.5 years.
- Higher magnetic susceptibility in the entorhinal cortex and putamen was linked to progression to mild cognitive impairment and faster cognitive decline.
- Positron emission tomography amyloid data were available for 110 participants, and elevated iron with amyloid burden showed synergistic acceleration of global decline.
- QSM provides a noninvasive estimate of regional brain iron and is positioned as a potential tool for risk stratification, trial enrichment, and exploration of iron-targeted therapies.
- The Johns Hopkins–led team and commentators urged validation in larger, more diverse cohorts and standardization of QSM methods before routine clinical adoption.